ROXANA LLOVET: Open Payments
NPI 1639250087 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 55 payments from 7 companies in 2025. Trend: 2023 $1,221 · 2024 $1,874 · 2025 $1,556
Food & beverage: $1,447Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $531 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $408 |
| E.R. Squibb & Sons, L.L.C. | 11 | $252 |
| Lundbeck LLC | 9 | $251 |
| Alkermes, Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, UZEDY, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, ARISTADA, INGREZZA, VIVITROL.
Industry payments across CT — which companies pay providers there.
